Arcadia Biosciences, Inc. (RKDA)
0.4726
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.4653
-0.01
(-1.54%)
After-Hours: 20:00
Arcadia Biosciences Total Assets (Quarterly) : 5.893M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.893M |
| March 31, 2026 | 5.323M |
| December 31, 2025 | 6.546M |
| September 30, 2025 | 8.584M |
| June 30, 2025 | 7.788M |
| March 31, 2025 | 12.99M |
| December 31, 2024 | 13.52M |
| September 30, 2024 | 15.24M |
| June 30, 2024 | 17.37M |
| March 31, 2024 | 16.05M |
| December 31, 2023 | 19.70M |
| September 30, 2023 | 23.47M |
| June 30, 2023 | 26.80M |
| March 31, 2023 | 30.41M |
| December 31, 2022 | 28.92M |
| September 30, 2022 | 34.47M |
| June 30, 2022 | 35.01M |
| March 31, 2022 | 38.80M |
| December 31, 2021 | 43.92M |
| September 30, 2021 | 59.23M |
| June 30, 2021 | 70.80M |
| March 31, 2021 | 70.80M |
| December 31, 2020 | 47.35M |
| September 30, 2020 | 33.88M |
| June 30, 2020 | 37.78M |
| Date | Value |
|---|---|
| March 31, 2020 | 32.25M |
| December 31, 2019 | 32.57M |
| September 30, 2019 | 37.30M |
| June 30, 2019 | 25.35M |
| March 31, 2019 | 21.95M |
| December 31, 2018 | 24.02M |
| September 30, 2018 | 27.22M |
| June 30, 2018 | 31.13M |
| March 31, 2018 | 22.60M |
| December 31, 2017 | 16.57M |
| September 30, 2017 | 18.98M |
| June 30, 2017 | 48.43M |
| March 31, 2017 | 52.65M |
| December 31, 2016 | 56.57M |
| September 30, 2016 | 61.59M |
| June 30, 2016 | 65.71M |
| March 31, 2016 | 70.10M |
| December 31, 2015 | 74.24M |
| September 30, 2015 | 79.97M |
| June 30, 2015 | 84.99M |
| March 31, 2015 | 19.42M |
| December 31, 2014 | 24.89M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Moolec Science SA | -- |
| Zivo Bioscience, Inc. | 0.4435M |
| PMGC Holdings, Inc. | 36.56M |
| Archer-Daniels-Midland Co. | 53.53B |
| Alico, Inc. | 198.66M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.26M |
| Shareholders Equity (Quarterly) | 0.633M |
| Current Ratio | 3.487 |
| Net Debt Paydown Yield | 0.28% |